How a new drug for COVID-19 could help improve treatment equity

A lab technician examines a pill. Seksan Mongkhonkhamsao via Getty Images
A technician examines a pill in a laboratory. Seksan Mongkhonkhamsao via Getty Images

Read next

Workers in Abuja, Nigeria, scan a box containing vials of a COVID-19 vaccine procured through COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, March 2, 2021.

One year in: Extraordinary achievement, powerful momentum, and still a shortfall for the ACT-Accelerator

The world must redouble its efforts to ensure global equity in COVID-19 vaccines, tests, and therapies.
By Mark Suzman Chief Executive Officer, Bill & Melinda Gates Foundation
Collaboration is the key to translating promising global health research into real-world solutions.

The Collaboratory: How sharing tools and technologies can shorten the timeline for global health R&D

Collaboration is the key to translating promising global health research into real-world solutions.
By Lynda Stuart Deputy Director, Vaccines & Human Immunology, Bill & Melinda Gates Foundation
Two women looking at medical notes

Gates Foundation COVID-19 Response FAQ

The most frequently asked questions about the foundation’s COVID-19 response answered.